20 Slash 20 Inc., the innovator behind The Eye Drink, has been featured in the coverage of the Moody Capital Solutions 2026 Disruptive Growth and Life Sciences Conference. This recognition underscores the company's role in addressing a growing public health concern: the impact of prolonged screen time on eye health.
The Eye Drink is marketed as the world’s first clinically inspired, ready-to-drink functional beverage specifically formulated to minimize ocular issues in today’s screen-heavy world. It is designed for individuals who spend long hours daily staring at computer or cellphone screens, with the goal of reducing screen-induced dry eyes and macular damage. The beverage leverages science-backed nutrients based on AREDS 2 Studies, along with vegan-friendly triglyceride-formed Omega-3, to protect visual performance and improve ocular comfort.
The significance of this product lies in its preventive approach. As digital device usage continues to rise globally, eye strain and related conditions have become increasingly common. By offering a convenient and enjoyable daily habit, The Eye Drink aims to transform clinical science into a simple solution that consumers can easily incorporate into their routines.
20 Slash 20 Inc. is modernizing preventive eyecare through multiple distribution channels, including direct-to-consumer sales, professional medical affiliates, and natural product retail stores. This multi-channel strategy enhances accessibility, allowing a broader audience to benefit from the product’s science-backed formulation.
The conference, organized by Moody Capital Solutions Inc., serves as a platform for disruptive growth and life sciences companies to present their innovations to the investment community. Moody Capital Solutions is an independent, full-service investment bank with more than 40 years of experience in capital raising, M&A, and advisory services. The company is recognized as a market leader in rights offerings and is a member of FINRA/SIPC.
IBN, a multifaceted financial news and publishing company, is providing comprehensive coverage of the conference through a custom-built portal. This portal includes summaries on each participating company, enabling efficient evaluation via one-click access to market research tools and helpful website links. IBN is also utilizing social media and syndicated articles to maximize the visibility of the event, ensuring that the innovations presented reach a wide audience of investors and industry observers.
For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts, and investment newsletters. Its syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily. This extensive reach amplifies the impact of the conference and highlights the potential of companies like 20 Slash 20 Inc.
The inclusion of 20 Slash 20 Inc. in this conference coverage is important because it brings attention to an emerging sector within the beverage industry: functional drinks targeting specific health concerns. As consumers become more health-conscious and screen reliance persists, products like The Eye Drink could see significant market growth. The conference provides a venue for such companies to gain investor interest and potentially accelerate their expansion.
For those interested in learning more about The Eye Drink or registering for the conference, additional information is available at theeyedrink.com and Moody Capital's conference page. Coverage of the conference by IBN can be viewed at IBN's conference coverage.
